Wickfield Bridge Fund

Wickfield Bridge Fund is a private investment vehicle primarily focused on the biopharmaceutical and life sciences sectors. It is most notably recognized as a foundational investor and significant shareholder in BridgeBio Pharma, a company dedicated to developing transformative medicines for genetic diseases and targeted oncology. The fund is managed by the leadership of Wickfield Capital, a diversified investment firm that provides strategic financial support for high-growth biotechnology innovation. While Wickfield Bridge Fund does not directly engage in laboratory research or clinical trials, its capital deployment has been instrumental in advancing a diverse pipeline of precision medicines. The entity serves as a key financial pillar within the ecosystem supporting the BridgeBio platform and its various subsidiary companies.